Size-Controlled Preparation of Docetaxel- and Curcumin-Loaded Nanoemulsions for Potential Pulmonary Delivery
Pharmaceutics · 15.02.2023 · 15 (2) · 652
DOI: 10.3390/pharmaceutics15020652 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 15.02.2023. Verfasst von Azren Aida Asmawi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Integrated Chemical BioPhysics Research, Department of Chemistry, Faculty of Science, Universiti Putra Malaysia, Serdang 43400, Malaysia. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Higher Education, Ministry of Health Malaysia, National Institute of Health, Ministry of Health Malaysia.
Abstract (Originalsprache)
Lung cancer is one of the deadliest pulmonary diseases in the world. Although docetaxel (DTX) has exhibited superior efficacy in lung cancer treatment, it has demonstrated numerous adverse effects and poor bioavailability. The natural product extract, curcumin (CCM), has reportedly reduced toxicity and synergistically improved DTX bioavailability. Nonetheless, the hydrophobic nature of DTX and CCM limits their clinical use. Nanoemulsion pulmonary delivery of DTX and CCM has demonstrated potential as a drug carrier to alleviate these drawbacks. The controlled preparation of inhalable DTX- and CCM-loaded nanoemulsions within the 100 to 200 nm range was explored in this study. A response surface methodology (RSM) based on a central composite design (CCD) was utilized to fabricate the desired size of the nanoemulsion under optimized conditions. Different process parameters were employed to control the size of the nanoemulsions procured through a high-energy emulsification technique. The size of the resultant nanoemulsions decreased with increasing energy input. The actual response according to the targeted sizes for DTX- and CCM-loaded nanoemulsion models exhibited excellent agreement with the predicted value at below 5% residual standard error under optimized conditions. The nanoemulsion of 100 nm particle size demonstrated better membrane permeability than their larger counterparts. Moreover, the formulations documented favorable physicochemical and aerodynamic pulmonary delivery properties and reduced toxicity in human lung fibroblast (MRC-5) cells. Hence, this tunable size of nanoemulsions could be a suitable alternative drug delivery for pulmonary diseases with increased local lung concentration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Integrated Chemical BioPhysics Research, Department of Chemistry, Faculty of Science, Universiti Putra Malaysia, Serdang 43400, Malaysia.
- UPM-MAKNA Cancer Research Laboratory, Institute of Bioscience, Universiti Putra Malaysia, Serdang 43400, Malaysia.
- Centre of Foundation Studies for Agricultural Science, Universiti Putra Malaysia, Serdang 43400, Malaysia.
ORCID-Profile: Norazlinaliza Salim, Mohd Basyaruddin Abdul Rahman
Förderung
- Ministry of Higher Education
- Ministry of Health Malaysia
- National Institute of Health, Ministry of Health Malaysia
Zitieren
APA
Asmawi, A. A., Salim, N., Abdulmalek, E., & Abdul Rahman, M. B. (2023). Size-Controlled Preparation of Docetaxel- and Curcumin-Loaded Nanoemulsions for Potential Pulmonary Delivery. Pharmaceutics, 15(2), 652. https://doi.org/10.3390/pharmaceutics15020652
Vancouver
Asmawi AA, Salim N, Abdulmalek E, Abdul Rahman MB. Size-Controlled Preparation of Docetaxel- and Curcumin-Loaded Nanoemulsions for Potential Pulmonary Delivery. Pharmaceutics. 2023;15(2):652. doi:10.3390/pharmaceutics15020652
BibTeX
@article{Asmawi2023,
author = {Asmawi, Azren Aida and Salim, Norazlinaliza and Abdulmalek, Emilia and Abdul Rahman, Mohd Basyaruddin},
title = {Size-Controlled Preparation of Docetaxel- and Curcumin-Loaded Nanoemulsions for Potential Pulmonary Delivery},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {2},
pages = {652},
doi = {10.3390/pharmaceutics15020652}
}
EUVIMED